CVA Family Office’s Geron GERN Stock Holding History

CVA Family Office’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-129	Closed	-$586	–	1311
2024 Q3	$586	Hold	129	–	–	﹤0.01%	1167
2024 Q2	$547	Buy	+129	New	+$503	﹤0.01%	1166

Other funds holding GERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CVA Family Office's GERN Position: Q4 2024 in Review

CVA Family Office sold out of Geron (GERN) in Q4 2024, closing a stake of 129 shares — an estimated $586 sold.

CVA Family Office first reported a position in GERN in Q2 2024 and held it in 2 quarters. The position peaked at $586 in Q3 2024. 285 funds tracked by Wall St. Rank hold GERN as of Q4 2024.

CVA Family Office reported no remaining Geron position as of Q4 2024 after selling out during the quarter.
CVA Family Office sold 129 Geron shares in Q4 2024, an estimated $586.
CVA Family Office first reported a position in Geron in Q2 2024 and held it in 2 quarters.
CVA Family Office's Geron position peaked at $586 in Q3 2024.
285 funds tracked by Wall St. Rank held Geron as of Q4 2024.

Based on CVA Family Office's 13F filing for Q4 2024, filed 7 Jan 2025.